Unnat Patel

The book · Chapter 9 of 16 · 2024– · Evidence · 4 minutes

Next · 10 When the context changes →

The gate

By Unnat Patel

Chapter 09 · Explore the idea

A fast answer still needs current context.

Freshness and responsiveness were simultaneous requirements in drug-utilisation review.

ANDBoth requirements matter
Evidence before change

Qualitative product requirements. No latency value, clinical threshold or pass result is implied.

Historical examples, disagreement analysis and specialist review informed readiness for the replacement.

Inside the decision

Current information

A quick review reflecting outdated context did not solve the same problem as a current, usable result.

Read supporting chapter text

Drug-utilisation review helps pharmacists assess interactions, allergies, contraindications, duplicate therapy and dose. In the workflow I worked on, information freshness and the responsiveness of the check both mattered. A review that arrives quickly but reflects outdated context does not solve the same problem as a current, usable result.

Inside the decision

Usable response time

I made the responsiveness budget part of acceptance, alongside understandable severity and acknowledgement.

Read supporting chapter text

The decision I owned was to modernize the supporting service rather than only improve its presentation. Synchronous interaction makes responsiveness part of the professional’s experience; asynchronous work has different tradeoffs around freshness and delay. I wrote requirements covering the relevant checks, understandable severity and acknowledgement, and made the responsiveness budget part of the acceptance discussion.

Inside the decision

Compare historical examples

We compared historical examples against the replacement and investigated disagreement classes.

Read supporting chapter text

Then the question that governs everything in this book: how do you establish sufficient evidence before changing a safety-related product? We compared historical examples against the replacement, investigated disagreement classes and used that evidence in readiness reviews with specialist partners. I wrote the launch communication against the criteria established before build, including responsiveness, successful handling and manual effort.

Inside the decision

Specialist readiness review

Responsible specialist partners reviewed the evidence before the product change.

Read supporting chapter text

Then the question that governs everything in this book: how do you establish sufficient evidence before changing a safety-related product? We compared historical examples against the replacement, investigated disagreement classes and used that evidence in readiness reviews with specialist partners. I wrote the launch communication against the criteria established before build, including responsiveness, successful handling and manual effort.

Inside the decision

The professional’s task

Throughput and user effort mattered alongside technical behavior.

Read supporting chapter text

I also worked on verification capabilities and the pharmacist’s experience. The product question was not simply whether the interface looked newer, but whether a professional could complete the task dependably. Throughput and user effort were adoption considerations alongside technical behavior. I connected the modernization with requirements and launch readiness.

Drug-utilisation review helps pharmacists assess interactions, allergies, contraindications, duplicate therapy and dose. In the workflow I worked on, information freshness and the responsiveness of the check both mattered. A review that arrives quickly but reflects outdated context does not solve the same problem as a current, usable result.

The decision I owned was to modernize the supporting service rather than only improve its presentation. Synchronous interaction makes responsiveness part of the professional’s experience; asynchronous work has different tradeoffs around freshness and delay. I wrote requirements covering the relevant checks, understandable severity and acknowledgement, and made the responsiveness budget part of the acceptance discussion.

Then the question that governs everything in this book: how do you establish sufficient evidence before changing a safety-related product? We compared historical examples against the replacement, investigated disagreement classes and used that evidence in readiness reviews with specialist partners. I wrote the launch communication against the criteria established before build, including responsiveness, successful handling and manual effort.

I also worked on verification capabilities and the pharmacist’s experience. The product question was not simply whether the interface looked newer, but whether a professional could complete the task dependably. Throughput and user effort were adoption considerations alongside technical behavior. I connected the modernization with requirements and launch readiness.

A smaller change taught the same lesson about ownership. A routine operational need depended on engineering assistance. I scoped a bounded self-service improvement with appropriate professional authority, so the person responsible for the work had a clearer way to complete it. The value came from removing an avoidable dependency, not adding another large platform.

Tools in this chapter AWS Fargate · Lambda (replay pipeline) · synchronous service design · drug-screening APIs · Identity verification service · CloudWatch · throughput dashboards · staged dial-up